Search

Author/Creator Bredewold, Obbo W

1. ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial. Issue 9 (21st September 2022)

Authors:
Dirikgil, Ebru; van Leeuwen, Jolijn R; Dam, Laura S van; Bredewold, Obbo W; Ray, Argho; Jonker, Jacqueline T; Soonawala, Darius; Remmelts, Hilde H F; van Dam, Bastiaan; Bos, Willem Jan; van Kooten, Cees; Rotmans, Joris; Rabelink, Ton; Teng, Y K Onno
Journal:
BMJ open
Issue:
Volume 12:Issue 9(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results. Issue 8 (27th June 2020)

Authors:
Kraaij, Tineke; Arends, Eline J; van Dam, Laura S; Kamerling, Sylvia W A; van Daele, Paul L A; Bredewold, Obbo W; Ray, Argho; Bakker, Jaap A; Scherer, Hans U; Huizinga, Tom J W; Rabelink, Ton J; van Kooten, Cees; Teng, Y K Onno
Journal:
Nephrology dialysis transplantation
Issue:
Volume 36:Issue 8(2021)
Page Start:
1474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P127 Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory SLE: two year results rituximab and belimumab combination for severe SLE. (23rd March 2020)

Authors:
Kraaij, Tineke; Arends, Eline J; van Dam, Laura S; Kamerling, Sylvia WA; Daele, Paul LA van; Bredewold, Obbo W; Ray, Argho; Bakker, Jaap A; Scherer, Hans U; Huizinga, Tom JW; Rabelink, Ton J; Kooten, Cees van; Teng, YK Onno
Journal:
Lupus science & medicine
Issue:
Volume 7(2020)Supplement 1
Page Start:
A90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗